Table 1 The global death and incidence of all cancers and 29 specified cancer groups in 1990 and 2017

Total-Neoplasms

5753 (5903–5661)

142.5 (145.89–140.47)

12,144 (14146–10595)

296.09 (349.12–255.32)

9556 (9692–9396)

121.21 (122.92–119.12)

24,362 (27310–21911)

306.75 (343.47–275.8)

Esophageal cancer

311 (323–301)

7.72 (8.01–7.48)

310 (322–301)

7.57 (7.85–7.33)

436 (448–425)

5.48 (5.63–5.34)

473 (485–459)

5.9 (6.06–5.74)

Stomach cancer

769 (795–752)

19.32 (19.96–18.91)

864 (890–847)

21.32 (21.95–20.9)

865 (885–848)

10.98 (11.23–10.77)

1221 (1255–1189)

15.36 (15.78–14.97)

Liver cancer

453 (490–426)

10.8 (11.68–10.18)

472 (512–445)

11.05 (11.97–10.42)

819 (856–790)

10.21 (10.65–9.85)

953 (997–917)

11.8 (12.34–11.35)

Larynx cancer

94 (97–91)

2.27 (2.34–2.2)

133 (136–129)

3.14 (3.22–3.06)

126 (130–123)

1.57 (1.61–1.53)

211 (216–206)

2.59 (2.65–2.54)

Tracheal, bronchus, and lung cancer

1033 (1063–1015)

25.54 (26.25–25.1)

1079 (1110–1060)

26.34 (27.05–25.89)

1883 (1923–1844)

23.74 (24.24–23.25)

2163 (2213–2117)

27.13 (27.75–26.55)

Breast cancer

350 (381–333)

8.66 (9.37–8.28)

879 (936–846)

20.91 (22.16–20.19)

612 (641–589)

7.65 (8.01–7.37)

1961 (2023–1891)

24.19 (24.96–23.34)

Cervical cancer

189 (210–173)

4.45 (4.96–4.1)

416 (466–383)

9.1 (10.17–8.4)

260 (269–241)

3.21 (3.32–2.98)

601 (625–554)

7.38 (7.67–6.81)

Uterine cancer

59 (61–56)

1.48 (1.54–1.43)

184 (189–178)

4.41 (4.53–4.28)

85 (87–83)

1.07 (1.1–1.05)

407 (418–397)

5 (5.14–4.88)

Prostate cancer

208 (235–165)

5.95 (6.66–4.68)

478 (533–359)

12.67 (14.06–9.49)

416 (490–357)

5.5 (6.46–4.71)

1334 (1698–1171)

16.94 (21.53–14.84)

Colon and rectum cancer

503 (526–488)

13.31 (13.87–12.96)

826 (855–807)

21.2 (21.87–20.75)

896 (916–876)

11.52 (11.77–11.27)

1833 (1873–1792)

23.22 (23.73–22.7)

Lip and oral cavity cancer

97 (102–94)

2.38 (2.47–2.29)

186 (192–180)

4.41 (4.55–4.28)

194 (202–185)

2.42 (2.52–2.31)

390 (404–374)

4.84 (5.02–4.65)

Nasopharynx cancer

52 (54–49)

1.19 (1.25–1.13)

87 (93–81)

1.88 (2–1.76)

70 (72–67)

0.86 (0.89–0.82)

110 (116–104)

1.35 (1.42–1.28)

Other pharynx cancer

56 (61–49)

1.32 (1.43–1.16)

78 (83–70)

1.8 (1.93–1.63)

117 (124–102)

1.45 (1.53–1.26)

179 (189–160)

2.19 (2.3–1.96)

Gallbladder and biliary tract cancer

106 (119–101)

2.79 (3.14–2.68)

120 (133–115)

3.13 (3.46–3.02)

174 (185–154)

2.23 (2.38–1.99)

211 (225–186)

2.71 (2.89–2.39)

Pancreatic cancer

196 (200–193)

5.1 (5.18–5.02)

195 (199–192)

5.01 (5.1–4.94)

441 (449–433)

5.62 (5.72–5.52)

448 (456–439)

5.69 (5.8–5.57)

Malignant skin melanoma

34 (43–28)

0.85 (1.07–0.71)

118 (147–93)

2.74 (3.42–2.17)

62 (70–48)

0.78 (0.89–0.61)

309 (366–238)

3.87 (4.58–2.97)

Non-melanoma skin cancer

30 (32–29)

0.83 (0.86–0.79)

3751 (5756–2235)

95.39 (149.21–55.03)

65 (66–63)

0.85 (0.87–0.82)

7664 (10570–5251)

97.11 (134.21–66.66)

Ovarian cancer

96 (101–92)

2.37 (2.49–2.28)

152 (162–145)

3.54 (3.76–3.4)

176 (181–171)

2.2 (2.26–2.14)

286 (295–278)

3.54 (3.66–3.44)

Testicular cancer

7 (7–6)

0.14 (0.15–0.13)

40 (41–38)

0.75 (0.78–0.72)

8 (8–7)

0.1 (0.1–0.09)

71 (74–69)

0.9 (0.94–0.87)

Kidney cancer

68 (71–63)

1.69 (1.75–1.56)

207 (220–189)

4.72 (4.95–4.29)

139 (143–129)

1.77 (1.82–1.64)

393 (405–371)

4.94 (5.08–4.66)

Bladder cancer

115 (118–108)

3.15 (3.24–2.99)

249 (256–237)

6.42 (6.58–6.13)

197 (206–192)

2.57 (2.69–2.51)

474 (492–462)

6.04 (6.27–5.9)

Brain and nervous system cancer

142 (171–117)

3.04 (3.58–2.56)

194 (234–159)

3.97 (4.71–3.33)

247 (265–213)

3.12 (3.34–2.68)

405 (443–351)

5.17 (5.64–4.46)

Thyroid cancer

22 (24–21)

0.55 (0.6–0.52)

95 (101–90)

2.11 (2.24–2.01)

41 (44–40)

0.52 (0.56–0.51)

255 (272–246)

3.15 (3.36–3.03)

Mesothelioma

17 (21–14)

0.44 (0.52–0.37)

21 (25–18)

0.52 (0.62–0.43)

30 (31–29)

0.38 (0.39–0.37)

35 (36–34)

0.44 (0.45–0.42)

Hodgkin lymphoma

36 (39–27)

0.75 (0.83–0.58)

73 (79–56)

1.43 (1.56–1.1)

33 (38–28)

0.41 (0.48–0.35)

101 (119–88)

1.29 (1.51–1.12)

Non-Hodgkin lymphoma

135 (142–130)

3.19 (3.34–3.1)

207 (217–200)

4.75 (4.93–4.62)

249 (253–243)

3.18 (3.24–3.11)

488 (497–479)

6.18 (6.29–6.06)

Multiple myeloma

52 (61–48)

1.35 1.59–1.26)

65 (77–60)

1.65 (1.93–1.52)

107 (119–99)

1.37 (1.51–1.25)

153 (173–141)

1.92 (2.17–1.76)

Leukemia

265 (293–234)

5.81 (6.32–5.27)

354 (399–308)

7.42 (8.17–6.62)

348 (365–317)

4.5 (4.73–4.12)

518 (548–472)

6.76 (7.16–6.15)

Other malignant neoplasms

220 (229–206)

5.07 (5.25–4.79)

308 (325–287)

6.74 (7.02–6.33)

360 (371–331)

4.61 (4.75–4.25)

716 (740–656)

9.16 (9.47–8.4)